1h-tetrazole has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhadada, SV; Hari Narayana Moorthy, NS; Karthikeyan, C; Maheshwari, N; Sahi, C; Trivedi, P; Verma, AK | 1 |
| Ikeda, H; Maekawa, T; Momose, Y; Odaka, H; Sohda, T | 1 |
2 other study(ies) available for 1h-tetrazole and Alloxan Diabetes
| Article | Year |
|---|---|
Synthesis and biological evaluation of some N-(3-(1H-tetrazol-5-yl) phenyl)acetamide derivatives as novel non-carboxylic PTP1B inhibitors designed through bioisosteric modulation.
Topics: Acetamides; Animals; Binding Sites; Blood Glucose; Diabetes Mellitus, Experimental; Drug Design; Enzyme Inhibitors; Glucose Tolerance Test; Humans; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Protein Structure, Tertiary; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Structure-Activity Relationship; Tetrazoles | 2018 |
Novel 5-substituted-1H-tetrazole derivatives as potent glucose and lipid lowering agents.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Hypolipidemic Agents; Mice; Mice, Inbred Strains; Obesity; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Tetrazoles; Transcription Factors; Triglycerides | 2002 |